Trial Outcomes & Findings for MOTIVATional intErviewing to Improve Self-care in Heart Failure Patients (NCT NCT02894502)

NCT ID: NCT02894502

Last Updated: 2021-03-17

Results Overview

Self-care in HF patients will be measured with the Self-Care of HF Index V.6.2. Since this instrument has three separate scales, we considered as a primary outcome the score of the Self-care Maintenance scale. The Self-Care Maintenance scale has a score between 0 and 100 with higher score meaning better self-care. Self-Care Maintenance is considered adequate when the score is at least 70.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

510 participants

Primary outcome timeframe

3 months from the intervention

Results posted on

2021-03-17

Participant Flow

Participant milestones

Participant milestones
Measure
Motivational Interviewing Only for Patients
In this arm the interventions will be delivered only to patients Motivational interviewing: The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
Motivational Interviewing to Patients and Caregivers
In this arm the interventions will be delivered both to patients and caregivers Motivational interviewing: The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
Control Group
This Group will receive the usual care
Baseline
STARTED
155
177
178
Baseline
COMPLETED
128
145
133
Baseline
NOT COMPLETED
27
32
45
First Follow up
STARTED
128
145
133
First Follow up
COMPLETED
94
114
93
First Follow up
NOT COMPLETED
34
31
40
Second Follow up
STARTED
94
114
93
Second Follow up
COMPLETED
79
96
79
Second Follow up
NOT COMPLETED
15
18
14
Third Follow up
STARTED
79
96
79
Third Follow up
COMPLETED
73
89
76
Third Follow up
NOT COMPLETED
6
7
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Motivational Interviewing Only for Patients
In this arm the interventions will be delivered only to patients Motivational interviewing: The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
Motivational Interviewing to Patients and Caregivers
In this arm the interventions will be delivered both to patients and caregivers Motivational interviewing: The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
Control Group
This Group will receive the usual care
Baseline
Withdrawal by Subject
24
31
36
Baseline
Death
3
1
9
First Follow up
Withdrawal by Subject
32
29
37
First Follow up
Death
2
2
3
Second Follow up
Withdrawal by Subject
13
15
13
Second Follow up
Death
2
3
1
Third Follow up
Withdrawal by Subject
5
6
3
Third Follow up
Death
1
1
0

Baseline Characteristics

In the "Motivational interviewing only for patients" and in the "Control group" Arms we have missing data.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Motivational Interviewing Only for Patients
n=155 Participants
In this arm the interventions will be delivered only to patients Motivational interviewing: The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
Motivational Interviewing to Patients and Caregivers
n=177 Participants
In this arm the interventions will be delivered both to patients and caregivers Motivational interviewing: The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
Control Group
n=178 Participants
This Group will receive the usual care
Total
n=510 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=154 Participants • In the "Motivational interviewing only for patients" and in the "Control group" Arms we have missing data.
0 Participants
n=177 Participants • In the "Motivational interviewing only for patients" and in the "Control group" Arms we have missing data.
0 Participants
n=177 Participants • In the "Motivational interviewing only for patients" and in the "Control group" Arms we have missing data.
0 Participants
n=508 Participants • In the "Motivational interviewing only for patients" and in the "Control group" Arms we have missing data.
Age, Categorical
Between 18 and 65 years
35 Participants
n=154 Participants • In the "Motivational interviewing only for patients" and in the "Control group" Arms we have missing data.
45 Participants
n=177 Participants • In the "Motivational interviewing only for patients" and in the "Control group" Arms we have missing data.
47 Participants
n=177 Participants • In the "Motivational interviewing only for patients" and in the "Control group" Arms we have missing data.
127 Participants
n=508 Participants • In the "Motivational interviewing only for patients" and in the "Control group" Arms we have missing data.
Age, Categorical
>=65 years
119 Participants
n=154 Participants • In the "Motivational interviewing only for patients" and in the "Control group" Arms we have missing data.
132 Participants
n=177 Participants • In the "Motivational interviewing only for patients" and in the "Control group" Arms we have missing data.
130 Participants
n=177 Participants • In the "Motivational interviewing only for patients" and in the "Control group" Arms we have missing data.
381 Participants
n=508 Participants • In the "Motivational interviewing only for patients" and in the "Control group" Arms we have missing data.
Age, Continuous
72.19 Years
STANDARD_DEVIATION 12.29 • n=154 Participants • In the first and in the third arm we have missing data
72.45 Years
STANDARD_DEVIATION 10.79 • n=177 Participants • In the first and in the third arm we have missing data
72.45 Years
STANDARD_DEVIATION 13.66 • n=177 Participants • In the first and in the third arm we have missing data
72.37 Years
STANDARD_DEVIATION 12.28 • n=508 Participants • In the first and in the third arm we have missing data
Sex: Female, Male
Female
75 Participants
n=155 Participants
70 Participants
n=177 Participants
69 Participants
n=178 Participants
214 Participants
n=510 Participants
Sex: Female, Male
Male
80 Participants
n=155 Participants
107 Participants
n=177 Participants
109 Participants
n=178 Participants
296 Participants
n=510 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=155 Participants
0 Participants
n=177 Participants
0 Participants
n=178 Participants
0 Participants
n=510 Participants
Race (NIH/OMB)
Asian
0 Participants
n=155 Participants
0 Participants
n=177 Participants
0 Participants
n=178 Participants
0 Participants
n=510 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=155 Participants
0 Participants
n=177 Participants
0 Participants
n=178 Participants
0 Participants
n=510 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=155 Participants
0 Participants
n=177 Participants
0 Participants
n=178 Participants
0 Participants
n=510 Participants
Race (NIH/OMB)
White
155 Participants
n=155 Participants
177 Participants
n=177 Participants
178 Participants
n=178 Participants
510 Participants
n=510 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=155 Participants
0 Participants
n=177 Participants
0 Participants
n=178 Participants
0 Participants
n=510 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=155 Participants
0 Participants
n=177 Participants
0 Participants
n=178 Participants
0 Participants
n=510 Participants
Self-Care of Heart Failure Index
45.72 units on a scale
STANDARD_DEVIATION 15.23 • n=155 Participants
45.98 units on a scale
STANDARD_DEVIATION 16.35 • n=177 Participants
44.98 units on a scale
STANDARD_DEVIATION 14.61 • n=178 Participants
45.55 units on a scale
STANDARD_DEVIATION 15.39 • n=510 Participants
Heart Failure Somatic Perception Scale
30.55 units on a scale
STANDARD_DEVIATION 18.20 • n=155 Participants
30.18 units on a scale
STANDARD_DEVIATION 18.25 • n=177 Participants
31.83 units on a scale
STANDARD_DEVIATION 18.95 • n=178 Participants
30.87 units on a scale
STANDARD_DEVIATION 18.46 • n=510 Participants
SF-12 (Physical Component Summary)
36.01 units on a scale
STANDARD_DEVIATION 10.35 • n=155 Participants
35.01 units on a scale
STANDARD_DEVIATION 9.16 • n=177 Participants
35.42 units on a scale
STANDARD_DEVIATION 9.30 • n=178 Participants
35.46 units on a scale
STANDARD_DEVIATION 9.57 • n=510 Participants

PRIMARY outcome

Timeframe: 3 months from the intervention

Self-care in HF patients will be measured with the Self-Care of HF Index V.6.2. Since this instrument has three separate scales, we considered as a primary outcome the score of the Self-care Maintenance scale. The Self-Care Maintenance scale has a score between 0 and 100 with higher score meaning better self-care. Self-Care Maintenance is considered adequate when the score is at least 70.

Outcome measures

Outcome measures
Measure
Motivational Interviewing Only for Patients
n=128 Participants
In this arm the interventions will be delivered only to patients Motivational interviewing: The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
Motivational Interviewing to Patients and Caregivers
n=145 Participants
In this arm the interventions will be delivered both to patients and caregivers Motivational interviewing: The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
Control Group
n=133 Participants
This Group will receive the usual care
Self-care Maintenance in Patients
52.36 score on a scale
Standard Deviation 22.67
54.23 score on a scale
Standard Deviation 20.36
49.63 score on a scale
Standard Deviation 17.49

SECONDARY outcome

Timeframe: 3, 6, 9 and 12 months from the intervention

Population: Patients with heart failure

Burden of HF symptoms will be measured with the Heart Failure Somatic Perception Scale (HFSPS). The HFSPS has a range score between 0 and 90; the higher the score, the higher the burden of symptoms caused by heart failure.

Outcome measures

Outcome measures
Measure
Motivational Interviewing Only for Patients
n=73 Participants
In this arm the interventions will be delivered only to patients Motivational interviewing: The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
Motivational Interviewing to Patients and Caregivers
n=89 Participants
In this arm the interventions will be delivered both to patients and caregivers Motivational interviewing: The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
Control Group
n=76 Participants
This Group will receive the usual care
Burden of HF Symptoms in Patients
24 score on a scale
Standard Deviation 16.5
17.4 score on a scale
Standard Deviation 18.8
22.5 score on a scale
Standard Deviation 21.7

SECONDARY outcome

Timeframe: 3, 6, 9 and 12 months from the intervention

Patient and caregiver generic physical and mental quality of life will be assessed with the Short Form 12 (SF-12).

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3, 6, 9 and 12 months from the intervention

Patient and caregiver anxiety and depression will be evaluated with the Hospital Anxiety and Depression Scale

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3, 6, 9 and 12 months from the intervention

Patient HF specific quality of life will be evaluated with the Kansas City Cardiomyopathy Questionnaire

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3, 6, 9 and 12 months from the intervention

We will use the Pittsburgh Sleep Quality Index

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3, 6, 9 and 12 months from the intervention

We will use the Mutuality Scale

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3, 6, 9 and 12 months from the intervention

Caregiver Preparedness will be evaluated with the Caregiver Preparedness Scale

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3, 6, 9 and 12 months from the intervention

We will use the Multidimensional Scale of Perceived Social Support Scale

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3, 6, 9 and 12 months from the intervention

The number of patient hospitalizations will be measured asking the caregiver how many time the patient was hospitalized from at 3, 6, 9 and 12 months from the intervention.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3, 6, 9 and 12 months from the intervention

How many times the patient has used the emergency services will be evaluated by asking the caregiver how many time the patient used after 3, 6, 9 and 12 months from the intervention.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3, 6, 9 and 12 months from the intervention

Population: The above participants were those who were randomized initially in the three arms.

Death rates will be evaluated in the three arms of the study by caregiver interview at 3, 6, 9 and 12 months from the intervention.

Outcome measures

Outcome measures
Measure
Motivational Interviewing Only for Patients
n=155 Participants
In this arm the interventions will be delivered only to patients Motivational interviewing: The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
Motivational Interviewing to Patients and Caregivers
n=177 Participants
In this arm the interventions will be delivered both to patients and caregivers Motivational interviewing: The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
Control Group
n=178 Participants
This Group will receive the usual care
Death
3 month follow-up · Overall Number of Participants Analyzed
128 Participants
145 Participants
133 Participants
Death
3 month follow-up · Number of Deaths
3 Participants
1 Participants
9 Participants
Death
3 month follow-up · Number of refusals to continue the study
24 Participants
31 Participants
36 Participants
Death
6 month follow-up · Overall Number of Participants Analyzed
94 Participants
114 Participants
93 Participants
Death
6 month follow-up · Number of Deaths
5 Participants
3 Participants
12 Participants
Death
6 month follow-up · Number of refusals to continue the study
56 Participants
60 Participants
73 Participants
Death
9 month follow-up · Overall Number of Participants Analyzed
79 Participants
96 Participants
79 Participants
Death
9 month follow-up · Number of Deaths
7 Participants
6 Participants
13 Participants
Death
9 month follow-up · Number of refusals to continue the study
69 Participants
75 Participants
86 Participants
Death
12 month follow-up · Overall Number of Participants Analyzed
73 Participants
89 Participants
76 Participants
Death
12 month follow-up · Number of Deaths
8 Participants
7 Participants
13 Participants
Death
12 month follow-up · Number of refusals to continue the study
74 Participants
81 Participants
89 Participants

Adverse Events

Motivational Interviewing Only for Patients

Serious events: 0 serious events
Other events: 0 other events
Deaths: 8 deaths

Motivational Interviewing to Patients and Caregivers

Serious events: 0 serious events
Other events: 0 other events
Deaths: 7 deaths

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 13 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Ercole Vellone

University of Rome Tor vergata, Rome, Italy

Phone: +393387491811

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place